Plunkett Research Online: Starpharma Holdings Limited

STARPHARMA HOLDINGS LIMITED (SPHRF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Starpharma Holdings Limited is a nanotechnology research company developing polyvalent technologies based on large molecules called dendrimers for drug development, life science and other applications. Dendrimers are synthetic nanoscale compounds that offer scientists predictable and manageable con.....



Starpharma Holdings Limited
Ticker: SPHRF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 61 385322700
Fax: 61 395105955
Address: 4-6 Southampton Crescent
Abbotsford
Melbourne, VIC 3067 Australia

Types Of Business
Industry Ranks

Industry NAICS code:

Nanotechnology Research & Development
Dendrimer-Based Pharmaceuticals
ContactsDescription

Jackie FairleyCEO
Nigel BaadeCFO
See More
Starpharma Holdings Limited is a nanotechnology research company developing polyvalent technologies based on large molecules called dendrimers for drug development, life science and other applications. Dendrimers are synthetic nanoscale compounds that offer scientists predictable and manageable con.....See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Starpharma Pty Ltd
Dendritic Nanotechnologies Inc
VivaGel
DEP
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: